Glaxosmithkline Capital Inc: 424B2 filed Sep 8, 2026

Form type

424B2

Filing date

Sep 8, 2026

Accession number

0001193125-26-384490

Filer

Glaxosmithkline Capital Inc (CIK 1224462)